Fondo Bibliografico Internacional Julio-Agosto 2006

Trasplante hepático

Liver biopsy interpretation for causes of late liver allograft dysfunction. Demetris AJ. Hepatology 2006;44:489-501.
Revisión.

Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation. Worns MA, Lohse AW, Neurath MF, Croxford A, Otto G, Kreft A, Galle PR, Kanzler S. American Journal of Gastroenterology 2006;101:1931-7.
Casos clínicos.

Probiotics: Application of "healthy" bacteria to liver transplant recipients. Levitsky J. Hepatology 2006;44:507-10.
Revisión.

Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). Samuel D, Forns X, Berenguer M, Trautwein C, Burroughs A, Rizzetto M, Trepo C. Journal of Hepatology 2006;45:127-43.
Documento de consenso: trasplante hepático en pacientes con hepatitis virales.

A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK. Liver Transplantation 2006;12:1049-61.
Utilidad pronóstica del índice MELD pre y post trasplante hepático.

Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients. Frilling A, Malago M, Weber F, Paul A, Nadalin S, Sotiropoulos GC, Cicinnati V, Beckebaum S, Bockisch A, Mueller-Brand J, Hofmann M, Schmid KW, Gerken G, Broelsch CE. Liver Transplantation 2006;12:1089-96.
Trasplante hepático en pacientes con metástasis hepáticas de tumores neuroendocrinos.

Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Cescon M, Varotti G, Ramacciato G, Vetrone G, Zanello M, Pinna AD. Liver Transplantation 2006;12:1104-11.
Recurrencia del VHC tras el trasplante hepático. Factores de riesgo y papel del retrasplante.

Isolated liver transplantation in infants with short gut syndrome: is less better? Mazariegos GV, Soltys KA, Bond GJ, Squires RH, Sindhi R. Liver Transplantation 2006;12:1040-1.
Editorial.

Treatment of HCV recurrence: do the pretransplantation rules apply? Burton JR, Rosen HR. Liver Transplantation 2006;12:1044-8.
Editorial.

Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome. Botha JF, Grant WJ, Torres C, Iverson AK, Sudan DL, Shaw BW Jr, Langnas AN. Liver Transplantation 2006;12:1062-6.
Utilidad del trasplante hepático aislado en niños con síndrome de intestino corto y enfermedad hepática avanzada.

Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C. Berenguer M, Palau A, Fernandez A, Benlloch S, Aguilera V, Prieto M, Rayon JM, Berenguer J. Liver Transplantation 2006;12:1067-76.
Recurrencia del VHC tras el trasplante hepático. La respuesta virológica precoz al tratamiento antiviral es un factor predictor de respuesta viral sostenida.

Selection of liver-transplant candidates for adult-to-adult living donor liver transplantation as the only surgical option for end-stage liver disease. Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Omata M, Makuuchi M. Liver Transplantation 2006;12:1077-83.
Aplicabilidad del trasplante hepático de donante vivo en regiones sin posibilidad de llevar a cabo trasplante de cadáver.

The natural history of hepatitis C virus in pediatric liver transplant recipients. Barshes NR, Udell IW, Lee TC, O'Mahony CA, Karpen SJ, Carter BA, Goss JA. Liver Transplantation 2006;12:1119-23.
Alta tasa de recurrencia del VHC en el trasplante hepático pediátrico.

Management of subcapsular hematoma of the graft after living donor liver transplantation. Kim DS, Lee SG, Sung GB, Ko GY, Park KM, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW. Liver Transplantation 2006;12:1124-8.
Tratamiento del hematoma subcapsular hepático en el trasplante hepático.

Hepatitis C, liver transplantation, and why we should consider children separately. Haber B. Liver Transplantation 2006;12:1042-3.
Editorial.

Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Christopher V, Al-Chalabi T, Richardson PD, Muiesan P, Rela M, Heaton ND, O'Grady JG, Heneghan MA. Liver Transplantation 2006;12:1138-43.
Evolución favorable de las getaciones tras el trasplante hepático.

Pregnancy after liver transplantation. Armenti VT. Liver Transplantation 2006;12:1037-9.
Editorial.

Does the Banff rejection activity index predict outcome in patients with early acute cellular rejection following liver transplantation? Horoldt BS, Burattin M, Gunson BK, Bramhall SR, Nightingale P, Hubscher SG, Neuberger JM. Liver Transplantation 2006;12:1144-51.
El índice histológico Banff que evalúa la gravedad del rechazo celular, no predice ni la respuesta a los esteroides, ni la supervivencia del injerto tras un trasplante hepático.

Resolution of severe graft steatosis following dual-graft living donor liver transplantation. Moon D, Lee S, Hwang S, Kim K, Ahn C, Park K, Ha T, Song G. Liver Transplantation 2006;12:1156-60.
Trasplante hepático de donante vivo empleando hígados esteatósicos. Casos clínicos.

Portal vein thrombosis: evolving techniques to attack this old nemesis. Perkins JD. Liver Transplantation 2006;12:1166-7.
Revisión.

"Exhausted" T cells: good or bad depends on your point of view. Perkins JD. Liver Transplantation 2006;12:1167-8.
Editorial.

Bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Perkins JD. Liver Transplantation 2006;12:1168-9.
Editorial.

Herpes simplex in a liver transplant recipient. Campsen J, Hendrickson R, Bak T, Wachs M, Kam I, Nash R, Russ P, Levi M. Liver Transplantation 2006;12:1171-3.
Caso clínico.

The safest way to play domino. Pacheco-Moreira LF, Enne M, Balbi E. Liver Transplantation 2006;12:1174.
Carta.

The safest way to play domino. Jabbour N, Gagandeep S. Liver Transplantation 2006;12:1175.
Carta.

Use of recombinant factor Vlla (rFVlla) in liver transportation. Planinsic RM. Liver Transplantation 2006;12:1176-9.
Carta.

Quality of life and liver transplantation in patients with polycystic liver disease. Dan AA, Younossi ZM. Liver Transplantation 2006;12:1184-5.
Editorial.

Treating hepatitis C infection in liver transplant recipients. Terrault NA, Berenguer M. Liver Transplantation 2006;12:1192-204.
Revisión.

Invasive aspergillosis in the recipients of liver retransplantation. Singh N, Pruett TL, Houston S, Munoz P, Cacciarelli TV, Wagener MM, Husain S. Liver Transplantation 2006;12:1205-9.
Aspergilosis invasiva en el retrasplante hepático.

Induction immunosuppression with rabbit antithymocyte globulin in pediatric liver transplantation. Shah A, Agarwal A, Mangus R, Lim J, Fridell J, Vianna R, Tector AJ. Liver Transplantation 2006;12:1210-4.
Utilidad de globulina antitimocítica en el trasplante pediátrico.

Portal vein reconstruction in adult living donor liver transplantation using cryopreserved vein grafts. Sugawara Y, Makuuchi M, Tamura S, Matsui Y, Kaneko J, Hasegawa K, Imamura H, Kokudo N, Motomura N, Takamoto S. Liver Transplantation 2006;12:1233-6.
Injertos criopreservados en la reconstrucción de la anastomosis portal en el tarsplante hepático de donante vivo.

Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome. Pungpapong S, Alvarez S, Hellinger WC, Kramer DJ, Willingham DL, Mendez JC, Nguyen JH, Hewitt WR, Aranda-Michel J, Harnois DM, Rosser BG, Hughes CB, Grewal HP, Satyanarayana R, Dickson RC, Steers JL, Keaveny AP. Liver Transplantation 2006;12:1244-52.
Peritonitis post-trasplante hepático: incidencia y significado pronóstico.

Bacterial- and fungal-positive cultures in organ donors: Clinical impact in liver transplantation. Cerutti E, Stratta C, Romagnoli R, Serra R, Lepore M, Fop F, Mascia L, Lupo F, Franchello A, Panio A, Salizzoni M. Liver Transplantation 2006;12:1253-9.
Mayor riesgo de transmisión de infecciones bacterianas o fúngicas a receptores de trasplante hepático si se emplean donantes añosos con estancias prolongadas en UCI.

Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation. Kirchner GI, Rifai K, Cantz T, Nashan B, Terkamp C, Becker T, Strassburg C, Barg-Hock H, Wagner S, Luck R, Klempnauer J, Manns MP. Liver Transplantation 2006;12:1268-77.
Importante mejoría de la calidad de vida de los pacientes con poliquistosis hepática sometidos a trasplante.

Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: A report of 2 cases and review of the literature. Aucejo F, Miller C, Vogt D, Eghtesad B, Nakagawa S, Stoller JK. Liver Transplantation 2006;12:1278-82.
Hipertensión pulmonar tras el trasplante hepático en pacientes con antecedentes de síndrome hepatopulmonar.

Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier. Zollner B, Feucht HH, Sterneck M, Schafer H, Rogiers X, Fischer L. Liver Transplantation 2006;12:1283-9.
Caso clínico.

Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: Use of polymerase chain reaction. Assi MA, Binnicker MJ, Wengenack NL, Deziel PJ, Badley AD. Liver Transplantation 2006;12:1290-2.
Utilidad de la PCR en el diagnóstico de la coccidioidomicosis.

Aprotinin: Effective, but risky? Perkins JD. Liver Transplantation 2006;12:1293-7.
Editorial.

Outflow reconstruction in domino liver transplantation with interposition of autologous portal vein graft. A new technical option in living donor domino liver transplant scenario. Cerqueira A, Pacheco-Moreira L, Enne M, Alves J, Amil R, Balbi E, Martinho JM. Liver Transplantation 2006;12:1298-300.
Caso clínico.